Building Concordant Ontologies for Drug Discovery. - Hande Küçük-McGinty; Saurabh Mehta; Yu Lin; Nooshin Nabizadeh; Vasileios Stathias; Dusica Vidovic; Amar Koleti; Christopher Mader; Jianbin Duan; Ubbo Visser; Stephan C. Schürer (ICBO/BioCreative, 2016)

The Cell Line Ontology Integration and Analysis of the Knowledge of LINCS Cell Lines. - Edison Ong; Jiangan Xie; Zhaohui Ni; Qingping Liu; Yu Lin; Vasileios Stathias; Caty Chung; Stephan C. Schürer; Yongqun He (ICBO/BioCreative, 2016)

Drug target ontology to classify and integrate drug discovery data. - Yu Lin; Saurabh Mehta; Hande Küçük-McGinty; John Paul Turner; Dusica Vidovic; Michele Forlin; Amar Koleti; Dac-Trung Nguyen; Lars Juhl Jensen; Rajarshi Guha; Stephen L. Mathias; Oleg Ursu; et al. (J. Biomed. Semant., 2017)

Ontological representation, integration, and analysis of LINCS cell line cells and their cellular responses. - Edison Ong; Jiangan Xie; Zhaohui Ni; Qingping Liu; Sirarat Sarntivijai; Yu Lin; Daniel J. Cooper; Raymond Terryn; Vasileios Stathias; Caty Chung; Stephan C. Schürer; Yongqun He (BMC Bioinform., 2017)

Data Portal for the Library of Integrated Network-based Cellular Signatures (LINCS) program: integrated access to diverse large-scale cellular perturbation response data. - Amar Koleti; Raymond Terryn; Vasileios Stathias; Caty Chung; Daniel J. Cooper; John Paul Turner; Dusica Vidovic; Michele Forlin; Tanya T. Kelley; Alessandro D'Urso; Bryce K. Allen; Denis Torre; et al. (Nucleic Acids Res., 2018)

DrugCentral 2018: an update. - Oleg Ursu; Jayme Holmes; Cristian Bologa; Jeremy J. Yang; Stephen L. Mathias; Vasileios Stathias; Dac-Trung Nguyen; Stephan C. Schürer; Tudor I. Oprea (Nucleic Acids Res., 2019)

LINCS Data Portal 2.0: next generation access point for perturbation-response signatures. - Vasileios Stathias; John Paul Turner; Amar Koleti; Dusica Vidovic; Daniel J. Cooper; Mehdi Fazel-Najafabadi; Marcin Pilarczyk; Raymond Terryn; Caty Chung; Afoma Umeano; Daniel J. B. Clarke; Alexander Lachmann; et al. (Nucleic Acids Res., 2020)